Viking Therapeutics (VKTX) Misses Q4 EPS by 48c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($1.38), $0.48 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'